Abstract:The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, other human coronaviruses (hCoVs) exist. Historical pandemics include smallpox and influenza, with efficacious therapeutics utilized to reduce overall disease burden through effectively targeting a competent host immune system response. The immune system is composed of primary/secondary lymphoid structures with initially eight types of immune cell types, and many other subtypes, traversing cell membranes utilizing cell signaling cascades that contribute towards clearance of pathogenic proteins. Other proteins discussed include cluster of differentiation (CD) markers, major histocompatibility complexes (MHC), pleiotropic interleukins (IL), and chemokines (CXC). The historical concepts of host immunity are the innate and adaptive immune systems. The adaptive immune system is represented by T cells, B cells, and antibodies. The innate immune system is represented by macrophages, neutrophils, dendritic cells, and the complement system. Other viruses can affect and regulate cell cycle progression for example, in cancers that include human papillomavirus (HPV: cervical carcinoma), Epstein–Barr virus (EBV: lymphoma), Hepatitis B and C (HB/HC: hepatocellular carcinoma) and human T cell Leukemia Virus-1 (T cell leukemia). Bacterial infections also increase the risk of developing cancer (e.g., Helicobacter pylori). Viral and bacterial factors can cause both morbidity and mortality alongside being transmitted within clinical and community settings through affecting a host immune response. Therefore, it is appropriate to contextualize advances in single cell sequencing in conjunction with other laboratory techniques allowing insights into immune cell characterization. These developments offer improved clarity and understanding that overlap with autoimmune conditions that could be affected by innate B cells (B1+ or marginal zone cells) or adaptive T cell responses to SARS-CoV-2 infection and other pathologies. Thus, this review starts with an introduction into host respiratory infection before examining invaluable cellular messenger proteins and then individual immune cell markers.

Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19

Innate immunity: the first line of defense against SARS-CoV-2

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

An Update on Innate Immune Responses during SARS-CoV-2 Infection

COVID-19 and the human innate immune system

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms

Synergism of TNF- and IFN- Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

Immune response induced by novel coronavirus infection

SARS-CoV-2, Inflammatory Apoptosis, and Cytokine Storm Syndrome

Insight into the Mechanisms of Coronaviruses Evading Host Innate Immunity.

Innate immune sensing of coronavirus and viral evasion strategies

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines

Innate immune responses to SARS-CoV-2

Immune Damage Mechanisms of COVID-19 and Novel Strategies in Prevention and Control of Epidemic

Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19

Insight into the Emerging Role of SARS-CoV-2 Nonstructural and Accessory Proteins in Modulation of Multiple Mechanisms of Host Innate Defense.

COVID-19: from immune response to clinical intervention.

The trinity of COVID-19: immunity, inflammation and intervention

SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets

Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions